Back to search results

A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Soft Tissue Sarcoma · Bone Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (John Livingston, MD) · jalivingston@mdanderson.org · 713-792-3626
    Contact: Principal Investigator (John Livingston, MD)
Study leads

  • John Livingston, MD

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)